Monday, February 25, 2013

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of EquEDGAR Online (Mon, Feb 25)

Friday, February 22, 2013

• Oxygen Biotherapeutics raise $2.1M in sale of preferred stock to investortheflyonthewall.com (Fri, Feb 22)
• Oxygen Biotherapeutics Enters into Definitive Agreements for Financing for up to $2.1 Million in Gross ProceedsBusiness Wire (Fri, Feb 22)

Wednesday, February 20, 2013

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other EventsEDGAR Online (Wed, Feb 20)
• Oxygen Biotherapeutics Announces Tentative Settlement of LitigationBusiness Wire (Wed, Feb 20)

Monday, February 11, 2013

• Oxygen Biotherapeutics Enters License and Supply Agreement for Dermacyte® Products with the Cosmetics Division of Valor SABusiness Wire (Mon, Feb 11)
• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other EventsEDGAR Online (Mon, Feb 11)

Wednesday, February 6, 2013

• Oxygen Biotherapeutics and the U.S. Army Institute of Surgical Research Sign a Cooperative Research and Development Agreement to Study the Effects of Oxycyte® on Ex Vivo Platelet FunctionBusiness Wire (Wed, Feb 6)

Wednesday, January 30, 2013

• Oxygen Biotherapeutics Announces It Will Present at the 15th Annual BIO CEO & Investor Conference on February 11Business Wire (Wed, Jan 30)

Tuesday, January 8, 2013

• Oxygen Biotherapeutics Announces It Will Present at OneMedForum Conference on Wednesday January 9thBusiness Wire (Tue, Jan 8)

Monday, December 17, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online (Mon, Dec 17)
• Oxygen Biotherapeutics Reports Second Quarter FY2013 Financial ResultsBusiness Wire (Mon, Dec 17)

Friday, December 14, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Fri, Dec 14)
• New Stock Coverage: Microsoft Still Has Major Issuesat Minyanville (Fri, Dec 14)

Thursday, December 6, 2012

• Oxygen Biotherapeutics Announces Second Quarter FY2013 Financial Results Conference Call and WebcastBusiness Wire (Thu, Dec 6)

Tuesday, November 20, 2012

• PPD to test Oxygen Biotherapeutics drugat bizjournals.com (Tue, Nov 20)
• Oxygen Biotherapeutics Engages PPD to Execute Remainder of Phase IIb Clinical Trial to Evaluate the Safety and Tolerability of Oxycyte® in Severe Traumatic Brain InjuryBusiness Wire (Tue, Nov 20)

Friday, October 26, 2012

• Oxygen trying to get proposed drug back on trackat bizjournals.com (Fri, Oct 26)

Thursday, October 25, 2012

• Oxygen trying to get proposed drug back on trackat bizjournals.com (Thu, Oct 25)

Monday, October 8, 2012

• Delisting danger deja vu for Oxygen Biotherapeuticsat bizjournals.com (Mon, Oct 8)

Friday, October 5, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule oEDGAR Online (Fri, Oct 5)

Wednesday, October 3, 2012

• Oxygen Biotherapeutics signs R&D agreement with U.S. Navyat theflyonthewall.com (Wed, Oct 3)

Friday, September 21, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule oEDGAR Online (Fri, Sep 21)

Thursday, September 20, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online (Thu, Sep 20)

Wednesday, September 19, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Wed, Sep 19)

Add OXBT News to My Yahoo!